SEC Form 4 · accession 0001179110-15-009159
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William K Heiden
Officer — CEO · Director
Period of report
Jun 2, 2015
Accepted (ET)
Jun 4, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2015 | F | 11,378 | $67.77 | D | 215,596 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 25,000 restricted stock units ("RSUs") on May 14, 2015. Due to the black-out policies implemented by AMAG Pharmaceuticals, Inc., the shares underlying such vested RSUs were not delivered to the reporting person until June 2, 2015, at which time an aggregate of 11,378 shares were withheld to satisfy the reporting person's applicable tax obligations.